Suche
Anzeige der Dokumente 1-10 von 424
Impaired function of primitive hematopoietic cells in mice lacking the Mixed-Lineage-Leukemia homolog Mll5
Wissenschaftlicher Artikel
(Universität Ulm, 2009)
Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia
Wissenschaftlicher Artikel
(Universität Ulm, 2002)
Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia
Wissenschaftlicher Artikel
(Universität Ulm, 2017)
Development of a real-time RT-PCR assay for the quantification of the most frequent MLL/AF9 fusion types resulting from translocation t(9;11)(p22;q23) in acute myeloid leukemia
Wissenschaftlicher Artikel
(Universität Ulm, 2003)
The prognostic value of MLL-AF9 detection in patients with t(9;11)(p22;q23)-positive acute myeloid leukemia
Wissenschaftlicher Artikel
(Universität Ulm, 2005)
All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study
Wissenschaftlicher Artikel
(Universität Ulm, 2016)
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
Wissenschaftlicher Artikel
(Universität Ulm, 2010)
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia, (CLL): results of a phase II study of the German CLL Study Group
Wissenschaftlicher Artikel
(Universität Ulm, 2001)
Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial
Wissenschaftlicher Artikel
(Universität Ulm, 2014)